Central China New Life Limited Issues Profit Warning for FY2025
Central China New Life Limited Issues Profit Warning for FY2025
Key Points for Investors
-
Significant Decline in Profit Expected: Central China New Life Limited (“the Company”, stock code: 9983) has issued a profit warning, announcing that its unaudited consolidated net profit for the year ending 31 December 2025 is expected to decrease by approximately 27% to 32% compared to RMB238.2 million recorded for the year ended 31 December 2024.
-
Profit Attributable to Shareholders: The profit attributable to shareholders is also expected to decrease by approximately 25% to 30% from RMB214.6 million in 2024.
-
Core Net Profit: Excluding certain non-cash and non-recurring items (such as net impairment losses, fair value changes, disposal gains/losses, share-based payments, and related tax effects), the decline in core net profit attributable to shareholders is expected to be not more than 10% versus RMB294.0 million in 2024.
Detailed Analysis of Financial Performance
The expected decline in net profit and profit attributable to shareholders is mainly due to:
-
Increased Impairment Losses: The Group anticipates a rise in net impairment losses on financial and contract assets for the year 2025 compared to 2024.
-
Decreased Gross Profit Margin: The Group’s gross profit margin for 2025 is expected to be lower, driven by:
-
Property Management Services: Increased costs in delivering higher-quality services to enhance customer satisfaction have compressed margins.
-
Value-Added Services: There has been a contraction in higher-margin services such as community value-added services and value-added services to non-property owners, primarily due to continued weakness in the real estate market and subdued consumer confidence domestically.
Implications for Shareholders
-
Price Sensitive Information: The scale of profit decline is significant and may directly impact investor sentiment and the Company’s share price. The announcement highlights both operational and market-driven challenges, including impairment losses and margin compression, that are likely to weigh on future earnings.
-
Non-Recurring Items: The Company notes that excluding certain non-cash and one-off items, the core profit decline is less severe, at not more than 10%. However, the market may focus on both reported and core profit figures.
-
Results Not Yet Audited: The figures disclosed are based on preliminary, unaudited management accounts for the year ended 31 December 2025. The results are subject to review and possible adjustment by the Company’s audit committee and auditors.
-
Publication Timeline: The final audited results for FY2025 are expected to be published in March 2026.
-
Caution Advised: Shareholders and potential investors are strongly advised to exercise caution when dealing in the Company’s shares during this period of uncertainty.
Board and Management
The Board of Directors comprises Mr. Wang Jun (Chairman), Mr. Yan Xuewen, and Mr. Guo Liyuan as executive directors, and Mr. Leong Chong, Ms. Luo Laura Ying, and Ms. Xin Zhu as independent non-executive directors.
Conclusion
This profit warning represents a material development for Central China New Life Limited, as it signals a substantial year-on-year decline in both statutory and core profits. The underlying causes—higher impairment losses, increased costs, and a challenging real estate environment—are likely to remain key concerns for investors. The announcement is highly price-sensitive and warrants close attention from shareholders and the investment community.
Disclaimer: The information presented is based on unaudited preliminary estimates provided by Central China New Life Limited. Actual results may differ after final audit review. Investors should read the Company’s forthcoming annual results announcement for complete and final figures. The author assumes no responsibility for investment actions taken based on this article.
View CC NEW LIFE Historical chart here